David Ian Wilson
Director · Neuphoria Therapeutics Inc.
Individual
- 2025
- Jan 21, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David Ian Wilson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Lynx1 Capital Management LP - $3.28M in NEUP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David Ian Wilson?
David Ian Wilson is a corporate insider, tracked as Director of Neuphoria Therapeutics Inc. (NEUP). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did David Ian Wilson last file a Form 4?
The most recent primary Form 4 on record is dated 21 January 2026, one of 2 filings going back to 2025.